<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Am J Med Genet C Semin Med Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Am J Med Genet C Semin Med Genet</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)1552-4876</journal-id>
<journal-id journal-id-type="publisher-id">AJMG</journal-id>
<journal-title-group>
<journal-title>American Journal of Medical Genetics. Part C, Seminars in Medical Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">1552-4868</issn>
<issn pub-type="epub">1552-4876</issn>
<publisher>
<publisher-name>John Wiley &amp; Sons, Inc.</publisher-name>
<publisher-loc>Hoboken, USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30253036</article-id>
<article-id pub-id-type="pmc">6635672</article-id>
<article-id pub-id-type="doi">10.1002/ajmg.c.31653</article-id>
<article-id pub-id-type="publisher-id">AJMGC31653</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Healthcare transition from childhood to adulthood in Tuberous Sclerosis Complex</article-title>
<alt-title alt-title-type="left-running-head">Peron et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes" id="ajmgc31653-cr-0001">
<name>
<surname>Peron</surname>
<given-names>Angela</given-names>
</name>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1769-6548</contrib-id>
<address>
<email>angela.peron@unimi.it</email>
</address>
<xref ref-type="aff" rid="ajmgc31653-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="ajmgc31653-aff-0002">
<sup>2</sup>
</xref>
<xref ref-type="bio" rid="d35e48">*</xref>
</contrib>
<contrib contrib-type="author" id="ajmgc31653-cr-0002">
<name>
<surname>Canevini</surname>
<given-names>Maria Paola</given-names>
</name>
<xref ref-type="aff" rid="ajmgc31653-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="bio" rid="d35e76">*</xref>
</contrib>
<contrib contrib-type="author" id="ajmgc31653-cr-0003">
<name>
<surname>Ghelma</surname>
<given-names>Filippo</given-names>
</name>
<xref ref-type="aff" rid="ajmgc31653-aff-0003">
<sup>3</sup>
</xref>
<xref ref-type="bio" rid="d35e96">*</xref>
</contrib>
<contrib contrib-type="author" id="ajmgc31653-cr-0004">
<name>
<surname>Di Marco</surname>
<given-names>Fabiano</given-names>
</name>
<xref ref-type="aff" rid="ajmgc31653-aff-0004">
<sup>4</sup>
</xref>
<xref ref-type="bio" rid="d35e116">*</xref>
</contrib>
<contrib contrib-type="author" id="ajmgc31653-cr-0005">
<name>
<surname>Vignoli</surname>
<given-names>Aglaia</given-names>
</name>
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4638-4663</contrib-id>
<xref ref-type="aff" rid="ajmgc31653-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="bio" rid="d35e138">*</xref>
</contrib>
</contrib-group>
<aff id="ajmgc31653-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Department of Health Sciences, Child Neuropsychiatry Unit ‐ Epilepsy Center, San Paolo Hospital</named-content>
<institution>Università degli Studi di Milano</institution>
<named-content content-type="city">Milan</named-content>
<country country="IT">Italy</country>
</aff>
<aff id="ajmgc31653-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Department of Pediatrics, Division of Medical Genetics</named-content>
<institution>University of Utah School of Medicine</institution>
<named-content content-type="city">Salt Lake City</named-content>
<named-content content-type="country-part">Utah</named-content>
</aff>
<aff id="ajmgc31653-aff-0003">
<label><sup>3</sup></label>
<named-content content-type="organisation-division">Department of Health Sciences, Disabled Advanced Medical Assistance, San Paolo Hospital</named-content>
<institution>Università degli Studi di Milano</institution>
<named-content content-type="city">Milan</named-content>
<country country="IT">Italy</country>
</aff>
<aff id="ajmgc31653-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Department of Health Sciences</named-content>
<institution>Università degli Studi di Milano (Italy), Respiratory Unit ASST‐Ospedale Papa Giovanni XXIII</institution>
<named-content content-type="city">Bergamo</named-content>
<country country="IT">Italy</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Angela Peron, Department of Health Sciences, Child Neuropsychiatry Unit ‐ Epilepsy Center (9° piano, blocco B), San Paolo Hospital, Università degli Studi di Milano, Ospedale San Paolo, Via di Rudinì 8, 20142 Milano, Italy.<break></break>
Email: <email>angela.peron@unimi.it</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>25</day>
<month>9</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2018</year>
</pub-date>
<volume>178</volume>
<issue>3</issue>
<issue-id pub-id-type="doi">10.1002/ajmg.c.v178.3</issue-id>
<issue-title content-type="special-issue-title">Special Issue on Tuberous Sclerosis Complex</issue-title>
<fpage>355</fpage>
<lpage>364</lpage>
<history>
<date date-type="received">
<day>01</day>
<month>7</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>20</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>8</month>
<year>2018</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 Wiley Periodicals, Inc. <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2018 The Authors American Journal of Medical Genetics Part C: Seminars in Medical Genetics Published by Wiley Periodicals, Inc.</copyright-statement>
<license license-type="creativeCommonsBy-nc">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:AJMG-178-355.pdf" xlink:type="simple"></self-uri>
<abstract>
<p>Healthcare transition from childhood to adulthood is required to ensure continuity of care of an increasing number of individuals with chronic conditions surviving into adulthood. The transition for patients with tuberous sclerosis complex (TSC) is complicated by the multisystemic nature of this condition, age‐dependent manifestations, and high clinical variability and by the presence of intellectual disability in at least half of the individuals. In this article, we address the medical needs regarding each TSC‐related manifestation in adulthood, and the services and support required. We review existing models of transition in different chronic conditions, discuss our experience in transitioning from the pediatric to the adult TSC Clinic at our Institution, and propose general rules to follow when establishing a transition program for TSC. Although a generalizable transition model for TSC is likely not feasible for all Institutions, a multidisciplinary TSC clinic is probably the best model, developed in accordance with the resources available and country‐specific healthcare systems. Coordination of care and education of the adult team should be always sought regardless of the transition model.</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="ajmgc31653-kwd-0001">adult care</kwd>
<kwd id="ajmgc31653-kwd-0002">adult manifestations</kwd>
<kwd id="ajmgc31653-kwd-0003">healthcare needs</kwd>
<kwd id="ajmgc31653-kwd-0004">pediatric care</kwd>
<kwd id="ajmgc31653-kwd-0005">transition</kwd>
<kwd id="ajmgc31653-kwd-0006">transitional program</kwd>
<kwd id="ajmgc31653-kwd-0007">TSC</kwd>
<kwd id="ajmgc31653-kwd-0008">tuberous sclerosis complex</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>Foundation Blanceflor Ludovisi, née Bildt</funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="7"></fig-count>
<table-count count="1"></table-count>
<page-count count="10"></page-count>
<word-count count="9313"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>component-id</meta-name>
<meta-value>ajmgc31653</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>September 2018</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.5 mode:remove_FC converted:17.07.2019</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="ajmgc31653-cit-9001" publication-type="journal">
<string-name>
<surname>Peron</surname>
<given-names>A</given-names>
</string-name>, <string-name>
<surname>Canevini</surname>
<given-names>MP</given-names>
</string-name>, <string-name>
<surname>Ghelma</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Di Marco</surname>
<given-names>F</given-names>
</string-name>, <string-name>
<surname>Vignoli</surname>
<given-names>A</given-names>
</string-name>. <article-title>Healthcare transition from childhood to adulthood in Tuberous Sclerosis Complex</article-title>. <source xml:lang="en"/>Am J Med Genet Part C. <year>2018</year>;<volume>178C</volume>:<fpage>355</fpage>–<lpage>364</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.c.31653</pub-id>
</mixed-citation>
</p>
<fn-group>
<fn id="ajmgc31637-note-1000">
<p>
<bold>Funding information</bold> Foundation Blanceflor Ludovisi, née Bildt</p>
</fn>
</fn-group>
</notes>
</front>
<body>
<sec id="ajmgc31653-sec-0001">
<label>1</label>
<title>INTRODUCTION</title>
<p>Healthcare transition is defined as the “purposeful, planned movement of adolescents and young adults with chronic physical and medical conditions from child‐centered to adult‐oriented health care systems” (Blum et al., <xref ref-type="ref" rid="ajmgc31653-bib-0006">1993</xref>). Quality healthcare should be continuous during transition for all young people, but for individuals with rare diseases and intellectual disability (ID), methods of transition differ from standard pathways.</p>
<p>The process of transition for people with special needs was designated as a top‐10 priority by the 2007 American Academy of Pediatrics Annual Leadership Forum. It begins in childhood/early adolescence and has the goal of helping children become as independent as possible as adults, and of seeking to meet their individual needs as they move into adulthood (American Academy of Pediatrics, American Academy of Family Physicians, &amp; American College of Physicians‐American Society of Internal Medicine, <xref ref-type="ref" rid="ajmgc31653-bib-0001">2002</xref>).</p>
<p>Unlike decades ago when a significant number of children with ID and/or birth defects died during childhood or adolescence, a larger number of these individuals now survive into adulthood thanks to improved diagnostic and therapeutic resources, and support services. Mortality during childhood in tuberous sclerosis complex (TSC) is low (Amin et al., <xref ref-type="ref" rid="ajmgc31653-bib-0003">2017</xref>), thus warranting that adult clinics be ready to provide long‐term care to these individuals. However, these patients and their families often face significant barriers in transitioning from the multidisciplinary pediatric healthcare system to an adult setting, which is generally individually based and less familiar with rare disorders (Royal College of Paediatrics and Child Health, <xref ref-type="ref" rid="ajmgc31653-bib-0051">2003</xref>).</p>
<p>The importance of transition is being increasingly recognized and has become a matter of discussion in the scientific community and among patient support organizations, including those focused on TSC (Both et al., <xref ref-type="ref" rid="ajmgc31653-bib-0008">2018</xref>). However, there are only a few articles in the literature that address transition in individuals with rare diseases (Waldboth, Patch, Mahrer‐Imhof, &amp; Metcalfe, <xref ref-type="ref" rid="ajmgc31653-bib-0060">2016</xref>), and international or national guidelines have not yet been delineated. A few pediatric centers have tried to establish transition programs in their practices, but no consensus on specific models for certain rare diseases have been obtained to date (American Academy of Pediatrics et al., <xref ref-type="ref" rid="ajmgc31653-bib-0002">2011</xref>; Carrizosa, An, Appleton, Camfield, &amp; Von Moers, <xref ref-type="ref" rid="ajmgc31653-bib-0012">2014</xref>; Reiss, Gibson, &amp; Walker, <xref ref-type="ref" rid="ajmgc31653-bib-0050">2005</xref>). Patient‐centered transition planning should be considered an aspect of standard healthcare and possibly become an integral part of medical training to bring about a change in attitudes in future generations of healthcare professionals (Van Lierde et al., <xref ref-type="ref" rid="ajmgc31653-bib-0057">2013</xref>). As a matter of fact, a consensus statement created by the Child Neurology Foundation in 2015 and endorsed by the American Academy of Neurology, the Child Neurology Society and the American Academy of Pediatrics proposed eight common principles that should be part of any transition model, including medical, legal, and reproductive issues (Brown et al., <xref ref-type="ref" rid="ajmgc31653-bib-0010">2016</xref>).</p>
<p>As for other medical conditions with multisystem involvement and ID, the ideal care for adult individuals with TSC should consider multidisciplinary specialty clinics designed to provide comprehensive care. Many of the medical issues change in adults with TSC: epilepsy may persist, as well as ID and mental health issues, but renal and/or pulmonary problems may become the most concerning issues, in terms of morbidity and occasionally mortality (Thiele, Granata, Matricardi, &amp; Chugani, <xref ref-type="ref" rid="ajmgc31653-bib-0054">2014</xref>). Indeed, dissemination of knowledge to the medical audience about TSC manifestations at different ages will improve the clinical management of adults with TSC.</p>
<p>Given the extremely wide clinical variability in TSC, it is impossible to generalize when discussing transition of care from childhood to adulthood in affected individuals. Some children have ID and will require a caregiver's assistance for their entire lives, while others have medical problems without cognitive impairment and will likely become independent in managing their own health. In this article, we will focus on the medical needs for each clinical manifestation in adulthood, and the services and support required. We will review existing models of transition in different conditions, discuss our experience, and propose general rules to follow when establishing a transition program for TSC. In the interest of conciseness, topics related to educational systems, employment and higher education, trust funds, respite care and residential options will not be covered here, but nevertheless remain important to consider when transitioning patients.</p>
</sec>
<sec id="ajmgc31653-sec-0002">
<label>2</label>
<title>CLINICAL MANIFESTATIONS OF TSC IN ADULTHOOD</title>
<sec id="ajmgc31653-sec-0003">
<label>2.1</label>
<title>Intellectual disability</title>
<p>The process of transition in individuals with ID can be especially challenging (Camfield et al., <xref ref-type="ref" rid="ajmgc31653-bib-0011">2017</xref>). About 50% of individuals with TSC have normal intellectual ability, and the remainders have varying levels of ID (Curatolo, Moavero, &amp; de Vries, <xref ref-type="ref" rid="ajmgc31653-bib-0019">2015</xref>), with epidemiological data reporting an over‐representation of severe and profound ID (Joinson et al., <xref ref-type="ref" rid="ajmgc31653-bib-0035">2003</xref>). Genotype–phenotype correlations show that ID is less frequent in patients with no mutation identified (NMI) compared to patients carrying demonstrable <italic>TSC2/TSC1</italic> mutations (Kothare et al., <xref ref-type="ref" rid="ajmgc31653-bib-0032">2014</xref>; Peron et al., <xref ref-type="ref" rid="ajmgc31653-bib-0049">2018</xref>). Also in individuals with normal intellectual abilities, specific learning, and attention/memory/executive function deficits can interfere with academic achievements and social functioning (Tierney, McCartney, Serfontein, &amp; de Vries, <xref ref-type="ref" rid="ajmgc31653-bib-0055">2011</xref>).</p>
<p>When addressing transition in individuals with ID, healthcare practitioners ought to also consider the life changes both patients and parents will encounter, and it is strongly advised that practical aspects such as guardianship, options for residential living facilities, aging parents, and future caregivers when parents pass away be addressed (Thiele et al., <xref ref-type="ref" rid="ajmgc31653-bib-0054">2014</xref>).</p>
</sec>
<sec id="ajmgc31653-sec-0004">
<label>2.2</label>
<title>Epilepsy</title>
<p>In a recent article, parents of patients with TSC identified epilepsy as one of the major concerns for their children and a limitation to their independent life (e.g., if seizures are drug resistant, a driver's license cannot be issued; Both et al., <xref ref-type="ref" rid="ajmgc31653-bib-0008">2018</xref>). Indeed, 90% of individuals with TSC have epilepsy at some point during their life, and two thirds of them develop medically refractory epilepsy (Thiele et al., <xref ref-type="ref" rid="ajmgc31653-bib-0054">2014</xref>). Regular neurological follow‐up and constant update of therapeutic strategies are mandatory for these patients. Moreover, chronic use of antiepileptic drugs (AEDs) and/or m‐TOR inhibitors should be monitored to minimize short and long‐term side effects.</p>
<p>The onset of epilepsy during adolescence and adulthood is uncommon, but may occur. It is also possible that adolescents and young adults experience a single seizure. In our experience, AEDs are not constantly required for these patients (Vignoli et al., <xref ref-type="ref" rid="ajmgc31653-bib-0058">2013</xref>). It also is important to note that some individuals with TSC experience remission of their epilepsy, and tapering off medications can be considered (Chu‐Shore, Major, Camposano, Muzykewicz, &amp; Thiele, <xref ref-type="ref" rid="ajmgc31653-bib-0015">2010</xref>; Vignoli et al., <xref ref-type="ref" rid="ajmgc31653-bib-0058">2013</xref>).</p>
</sec>
<sec id="ajmgc31653-sec-0005">
<label>2.3</label>
<title>Other neuropsychiatric disorders</title>
<p>Although often present since childhood, a wide range of psychological and behavioral manifestations (Tuberous sclerosis‐Associated Neuropsychiatric Disorders [TAND]) may appear, persist, or become more significant during adulthood (Curatolo et al., <xref ref-type="ref" rid="ajmgc31653-bib-0019">2015</xref>; Thiele et al., <xref ref-type="ref" rid="ajmgc31653-bib-0054">2014</xref>). During their lifetime, several individuals with TSC will present with behavioral issues, such as aggression, tantrums, self‐injury, and sleep difficulties (Eden, de Vries, Moss, Richards, &amp; Oliver, <xref ref-type="ref" rid="ajmgc31653-bib-0021">2014</xref>; Wilde et al., <xref ref-type="ref" rid="ajmgc31653-bib-0062">2017</xref>). Anxiety and depressive disorders are often identified from early adolescence and in adulthood, in contrast with psychotic disorders, occurring as commonly as in the general population (about 1%) (Leclezio &amp; de Vries, <xref ref-type="ref" rid="ajmgc31653-bib-0038">2015</xref>).</p>
<p>Neurodevelopmental disorders, such as autism spectrum disorder (ASD, 40%–50%) and attention deficit hyperactivity disorder (30%–50%), are common in TSC (Curatolo et al., <xref ref-type="ref" rid="ajmgc31653-bib-0019">2015</xref>). ASD has demonstrated to be related to epilepsy, infantile spasms, and mutations in <italic>TSC2</italic> (Vignoli et al., <xref ref-type="ref" rid="ajmgc31653-bib-0059">2015</xref>) and may result in a major burden of care especially in adulthood when rehabilitation facilities are often no longer available. Furthermore, transition into adulthood often involves loss of school support and child and adolescence mental health support, known to be a challenge in ASD in general (Lai, Lombardo, &amp; Baron‐Cohen, <xref ref-type="ref" rid="ajmgc31653-bib-0037">2014</xref>).</p>
<p>Whenever diagnosed, TAND should be treated with specific symptomatic therapies. The potential role of mTOR inhibitors for improving neurocognitive functioning and behavior is still debated (Kilincaslan et al., <xref ref-type="ref" rid="ajmgc31653-bib-0029">2017</xref>; Krueger et al., <xref ref-type="ref" rid="ajmgc31653-bib-0034">2017</xref>).</p>
<p>Transition may therefore be the right time to investigate all levels of TAND, especially if they have been under‐recognized during childhood and particularly in individuals with normal intelligence, as they prepare to finds jobs and live independent lives.</p>
</sec>
<sec id="ajmgc31653-sec-0006">
<label>2.4</label>
<title>Renal manifestations</title>
<p>Renal cysts and angiomyolipomas are the main manifestations of TSC affecting the kidneys, although angiomyolipomas can be found also in other organs (i.e., the liver) (Northrup &amp; Krueger, <xref ref-type="ref" rid="ajmgc31653-bib-0046">2013</xref>). While cysts are a major concern in children, especially those who have a contiguous gene deletion involving both <italic>TSC2</italic> and <italic>PKD1</italic>, renal angiomyolipomas represent the main renal cause of morbidity and mortality in adult individuals with TSC (Shepherd, Gomez, Lie, &amp; Crowson, <xref ref-type="ref" rid="ajmgc31653-bib-0052">1991</xref>). The occurrence of renal angiomyolipomas is age dependent, with more than 80% affected by age 18 years (Hamer et al., <xref ref-type="ref" rid="ajmgc31653-bib-0024">2018</xref>). Although angiomyolipomas are benign tumors, they are highly vascular and can encounter spontaneous bleeding, usually presenting with abrupt abdominal pain and hematuria. Sudden bleeding of an angiomyolipoma requires embolization, can be life threatening and sometimes lead to renal insufficiency requiring dialysis and/or renal transplant (Kingswood et al., <xref ref-type="ref" rid="ajmgc31653-bib-0030">2016</xref>). Fortunately, the use of mTOR inhibitors is changing the natural history of angiomyolipomas, reducing the size of the lesions in the majority of patients, and preventing major complications in an increasing number of individuals (Bissler et al., <xref ref-type="ref" rid="ajmgc31653-bib-0005">2017</xref>). TSC patients are also at risk of developing renal cell carcinoma at a younger age than the general population (Peron et al., <xref ref-type="ref" rid="ajmgc31653-bib-0048">2016</xref>).</p>
<p>A recent European survey pointed out the limited knowledge of renal angiomyolipomas in TSC patients and caregivers, and the poor adherence to the surveillance guidelines (i.e., renal imaging every 1–3 years, assessment of renal function and blood pressure yearly, from Krueger &amp; Northrup, <xref ref-type="ref" rid="ajmgc31653-bib-0046">2013</xref>), especially in the individuals older than age 15 years (Cockerell et al., <xref ref-type="ref" rid="ajmgc31653-bib-0016">2018</xref>). For these reasons, providers are encouraged to carefully instruct patients and families about the possible consequences of angiomyolipomas, the need to continue screening and/or treatment, and the available therapeutic options when transferring the care to an adult clinic.</p>
</sec>
<sec id="ajmgc31653-sec-0007">
<label>2.5</label>
<title>Pulmonary manifestations</title>
<p>Pulmonary manifestations of TSC include: lymphangioleiomyomatosis (LAM), found in about 75% of women with TSC, and characterized by proliferation of bundles of smooth muscle cells, resultant in cystic changes in the lung parenchyma; multifocal micronodular pneumocytic hyperplasia (MMPH), caused by the growth of proliferating epithelial cells into the alveolar walls, present with or without LAM in up to 60% of patients with TSC; and rarely clear cell lung tumor. Clinically, LAM can manifest with exertional dyspnea, recurrent pneumothoraces, thoracic lymphadenopathy, and hemoptysis (Johnson et al., <xref ref-type="ref" rid="ajmgc31653-bib-0027">2010</xref>), while the presence of MMPH is not associated with a specific clinical or functional profile (Di Marco et al., <xref ref-type="ref" rid="ajmgc31653-bib-0020">2016</xref>). Even if in some cases LAM is the reason for diagnosis of TSC during infancy (Hancock, Tomkins, Sampson, &amp; Osborne, <xref ref-type="ref" rid="ajmgc31653-bib-0025">2002</xref>), usually the pulmonary manifestations of TSC are typically only seen in adult women, since “age” has been found to be the only independent condition associated with the development of LAM (Di Marco et al., <xref ref-type="ref" rid="ajmgc31653-bib-0020">2016</xref>). In most cases, the diagnosis results from proactive screening, as CT scans are recommended for women with TSC at ages between 18 and 30 years, even if asymptomatic (Krueger &amp; Northrup, <xref ref-type="ref" rid="ajmgc31653-bib-0033">2013</xref>). Therefore, the process of transition is not expected, with few exceptions, to be challenging for pulmonary involvement.</p>
</sec>
<sec id="ajmgc31653-sec-0008">
<label>2.6</label>
<title>Cutaneous manifestations</title>
<p>Hypomelanotic macules, poliosis and “confetti” skin lesions, facial angiofibromas, fibrous cephalic plaque, ungual fibromas, shagreen patch, dental enamel pits, and intraoral fibromas are the main dermatological and dental signs in patients with TSC (Northrup &amp; Krueger, <xref ref-type="ref" rid="ajmgc31653-bib-0033">2013</xref>). Most of them—except for ungual fibromas—develop in childhood and are not associated with major medical concerns, although they can be one of the most useful diagnostic findings. However, facial angiofibromas can increase in number and size over time or bleed, causing cosmetic and dysfunctional problems. Healthcare practitioners should not underestimate the impact of potentially disfiguring lesions, which may lead to psychological discomfort especially in adolescents and young adults, and it is advised to refer patients for evaluation of treatment as part of the transition process. Suggested useful interventions include surgical excision, lasers, and use of topical mTOR inhibitors (Koenig et al., <xref ref-type="ref" rid="ajmgc31653-bib-0031">2018</xref>; Malissen et al., <xref ref-type="ref" rid="ajmgc31653-bib-0039">2017</xref>; Wataya‐Kaneda et al., <xref ref-type="ref" rid="ajmgc31653-bib-0061">2017</xref>). As there is no evidence on which intervention is more effective, the 2012 TSC Dermatology and Dentistry Subcommittee recommended that the choice be based on available recourses and clinician expertise, considering if the patient is or will soon be on systemic mTOR inhibitors (Teng et al., <xref ref-type="ref" rid="ajmgc31653-bib-0053">2014</xref>).</p>
</sec>
<sec id="ajmgc31653-sec-0009">
<label>2.7</label>
<title>Cardiac findings</title>
<p>Cardiac rhabdomyomas are early signs of TSC, often discovered at prenatal ultrasound, but they may also be detected later on in life as part of the diagnostic workup or after the TSC diagnosis, especially if they are asymptomatic. Unless the cardiac rhabdomyomas are symptomatic (in which case an echocardiogram should be performed until regression is documented), adult patients should receive a 12‐lead ECG every 3–5 years to monitor for conduction defects, according to the guidelines (Krueger &amp; Northrup, <xref ref-type="ref" rid="ajmgc31653-bib-0033">2013</xref>).</p>
</sec>
<sec id="ajmgc31653-sec-0010">
<label>2.8</label>
<title>Ocular manifestations</title>
<p>TSC patients can exhibit multiple retinal hamartomas and/or retinal achromic patches, which are useful in the diagnostic process but do not usually cause problems with vision. An annual ophthalmologic evaluation is recommended (Krueger &amp; Northup, <xref ref-type="ref" rid="ajmgc31653-bib-0033">2013</xref>). However, in our opinion, this could be performed as part of the regular ophthalmologic screening as in the general population, especially if an adult ophthalmologist is not part of the TSC clinic.</p>
</sec>
<sec id="ajmgc31653-sec-0011">
<label>2.9</label>
<title>Bone findings</title>
<p>Two main considerations should be made for bone‐related problems in adult TSC patients. The first one concerns bone manifestations in this condition, consisting of sclerotic bone lesions, bone cysts, and fibrous dysplasia. Sclerotic bone lesions are usually multiple and can be present in up to 90% of adult patients (Avila et al., <xref ref-type="ref" rid="ajmgc31653-bib-0004">2010</xref>; Boronat, Barber, &amp; Thiele, <xref ref-type="ref" rid="ajmgc31653-bib-0007">2017</xref>). Although they might not be specific for TSC, recent evidence from a case–control study evaluating CT scans of 49 adults with TSC suggests that sclerotic bone lesions are found more frequently in TSC patients than in the general population (Brakemeier et al., <xref ref-type="ref" rid="ajmgc31653-bib-0009">2018</xref>).</p>
<p>They are not of clinical concern, and the 2012 International Tuberous Sclerosis Complex Consensus Group concluded that routine evaluation of bone findings in TSC is not supported by sufficient evidence unless there are clinical symptoms (Krueger &amp; Northrup, <xref ref-type="ref" rid="ajmgc31653-bib-0033">2013</xref>). However, physicians caring for adult TSC patients—including family doctors and radiologists—need to be aware that these individuals can show bone lesions, so to recognize and distinguish them from more serious manifestations not related to TSC, that is, osteoblastic metastases, to avoid misdiagnoses of cancer, as happened in one of our patients (personal communication).</p>
<p>The second consideration regards bone health in TSC patients affected by seizures. Adolescents with epilepsy have a higher risk of reduced bone mineral density and consequent fractures, and a substantial number of AEDs are associated with adverse effects on the bone through cytochrome P450 enzyme‐induced increased vitamin D metabolism, or other mechanisms (Camfield et al., <xref ref-type="ref" rid="ajmgc31653-bib-0011">2017</xref>). Although there are no specific guidelines for bone health assessment in individuals with TSC, neurologists in the TSC clinics should request screening of 25‐hydroxyvitamin D and possibly consider referring patients on polytherapy for DEXA scan, as suggested by Camfield et al. (<xref ref-type="ref" rid="ajmgc31653-bib-0011">2017</xref>), especially if their mobility is reduced.</p>
</sec>
<sec id="ajmgc31653-sec-0012">
<label>2.10</label>
<title>Reproductive system and genetic counseling</title>
<p>During the transition period and/or after transition has been completed, there are two main points to consider regarding genetics.</p>
<p>The first one concerns molecular testing. Some of the patients diagnosed with TSC in early years may have only a clinical diagnosis, as genetic testing might have not been performed in the past. At this point of time, it is important to offer molecular analysis, as this will have clinical implications for genetic counseling especially related to reproductive choices. In our opinion, reports of genetic testing performed in the past and with a negative result or with variants of unknown significance should be reviewed, and a re‐evaluation of those results and/or testing with Next Generation Sequencing (NGS) techniques can be offered. As a matter of fact, a pathogenic variant—mosaic or in noncoding regions—is likely to be identified in more and more patients who had no mutation identified in the past, thanks to NGS (Nellist et al., <xref ref-type="ref" rid="ajmgc31653-bib-0044">2015</xref>; Tyburczy et al., <xref ref-type="ref" rid="ajmgc31653-bib-0056">2015</xref>).</p>
<p>The second point to consider is family planning and genetic counseling, especially for those individuals with normal or borderline cognitive functioning who are likely to reproduce. Assuming that the parents have knowledge about the genetics of TSC, we suggest that recurrence risk be gradually introduced to the patient when the transition process starts in teen ages. The best timing is probably when parents and providers agree that the adolescents have sufficient maturity to understand it. A genetics visit, a separate genetic counseling session or multiple sessions may be necessary based on the context. The provider will gradually address recurrence risk, clinical variability (even in members of the same family), any genotype–phenotype correlations if available for few specific mutations, possible options for preimplantation genetic diagnosis and prenatal diagnosis if the pathogenic variant is known, and other reproductive options, such as adoption (Northrup, Koenig, Pearson &amp; Au, <xref ref-type="ref" rid="ajmgc31653-bib-0045">1999</xref>). The three‐generation pedigree should also be updated to determine if additional family members are at risk of TSC. When appropriate, birth control options and/or changes in therapies should be discussed as well, especially with regard to possible teratogenicity of certain drugs (i.e., AEDs) and the effect of estrogen‐containing contraception and pregnancy itself on LAM.</p>
</sec>
</sec>
<sec id="ajmgc31653-sec-0013">
<label>3</label>
<title>MODELS OF TRANSITION IN OTHER DISEASES</title>
<p>Although the needs of patients and families during the transitional period have been recognized (Both et al., <xref ref-type="ref" rid="ajmgc31653-bib-0008">2018</xref>) and the TSC community has dedicated an educational track to transition during the 2018 TSC World Conference held in Dallas, we are not aware of specific guidelines or proposed models of transition in TSC. However, several examples from other chronic conditions, both genetic and nongenetic, are available in the scientific literature, and policy documents support the need for transition models (Van Lierde et al., <xref ref-type="ref" rid="ajmgc31653-bib-0057">2013</xref>; Couce et al., <xref ref-type="ref" rid="ajmgc31653-bib-0017">2018</xref>; Chabrol et al., <xref ref-type="ref" rid="ajmgc31653-bib-0013">2018</xref>). Although each transition program has its own characteristics and no formal evaluation has been made for most of them, the main models that have been utilized can be summarized as follows:<list id="ajmgc31653-list-0001" list-type="order"><list-item id="ajmgc31653-li-0001"><p>The model of “transfer with referral letter”: transition is planned at an interdisciplinary meeting with healthcare providers and patients/families, and a clinical summary written by the pediatric team is given to the adult team, who has access to the pediatric medical records of the patient. This model implies an adult clinic only. An example is the Phenylketonuria clinic in Leipzig, Germany (Mütze et al., <xref ref-type="ref" rid="ajmgc31653-bib-0040">2011</xref>), with good clinical and social outcomes (Mütze et al., <xref ref-type="ref" rid="ajmgc31653-bib-0041">2016</xref>). Similarly, a referral letter is written by the pediatric provider to the adult one, and the patient is seen in the adult setting with no further communication in some transition programs for epilepsy in Canada and France (Carrizosa et al., <xref ref-type="ref" rid="ajmgc31653-bib-0012">2014</xref>).</p></list-item><list-item id="ajmgc31653-li-0002"><p>The “joint clinic” transition model: in this model, patients and families are prepared to transition during the pediatric clinic, then the pediatric physician transfers all medical records to the adult team and attends the first adult clinic (1–4 visits), in addition to being available to support and educate the adult team. The joint visits can take place at either the pediatric or adult hospital. When the process is completed, the patient is seen in the adult setting. Examples of this model are the transition epilepsy clinics in the United Kingdom (Carrizosa et al., <xref ref-type="ref" rid="ajmgc31653-bib-0012">2014</xref>) and the Cystic Fibrosis transition clinic at the University of Michigan (Chaudhry, Keaton, &amp; Nasr, <xref ref-type="ref" rid="ajmgc31653-bib-0014">2013</xref>). This model allows patients to meet and trust the new providers without feeling simply discharged by the pediatric ones. However, it requires time from both parties and enormous economic resources.</p></list-item><list-item id="ajmgc31653-li-0003"><p>The “teenager/transition clinic” model: in this model, clinics dedicated to adolescents have been established. The clinic is held by professionals who have received specialized training, and takes place in appropriate spaces (Kerr, Kluger, &amp; Philip, <xref ref-type="ref" rid="ajmgc31653-bib-0028">2011</xref>). An example of this model is the Adolescence Epilepsy Transition Clinic at the University of Alberta Hospital in Canada (Jurasek, Ray, &amp; Quigley, <xref ref-type="ref" rid="ajmgc31653-bib-0036">2010</xref>). The aim of this model is to provide an adequate setting between the pediatric and adult ones.</p></list-item></list>
</p>
<p>Of note, although most of the transition programs described in the literature had statistically significant positive outcomes (Gabriel, McManus, Rogers, &amp; White, <xref ref-type="ref" rid="ajmgc31653-bib-0022">2017</xref>), some of them were discontinued when physicians retired or moved to different hospitals and others were too expensive to be maintained, thus highlighting the difficulties in maintaining such complex programs (Carrizosa et al., <xref ref-type="ref" rid="ajmgc31653-bib-0012">2014</xref>).</p>
</sec>
<sec id="ajmgc31653-sec-0014">
<label>4</label>
<title>OUR EXPERIENCE</title>
<p>Since 2001, at San Paolo University Hospital in Milan (Italy), a multidisciplinary group of physicians developed experience in caring for patients with TSC. The TSC clinic was developed following the need of pediatric and adult neurologists of the Epilepsy Center to involve other specialists in the care of TSC patients, and is directed by the Director of the Epilepsy Center. The list of healthcare practitioners involved in the TSC clinic is listed in Table <xref ref-type="table" rid="ajmgc31653-tbl-0001">1</xref>, and a schematic overview is presented in Figure <xref ref-type="fig" rid="ajmgc31653-fig-0001">1</xref>.</p>
<table-wrap id="ajmgc31653-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>List of healthcare practitioners involved in the pediatric and adult TSC clinic of San Paolo University Hospital in Milan, Italy</p>
</caption>
<table frame="hsides" rules="groups">
<col align="left" span="1"/>
<col align="left" span="1"/>
<thead valign="bottom">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="bottom">Pediatric TSC clinic</th>
<th align="left" colspan="1" rowspan="1" valign="bottom">Adult TSC clinic</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pediatric neurology</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurology</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pediatric psychiatry</td>
<td align="left" colspan="1" rowspan="1" valign="top">Psychiatry</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Medical genetics</td>
<td align="left" colspan="1" rowspan="1" valign="top">Medical genetics</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pediatrics</td>
<td align="left" colspan="1" rowspan="1" valign="top">DAMA (internal medicine/general surgery)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Nephrology</td>
<td align="left" colspan="1" rowspan="1" valign="top">Nephrology</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Pulmonology (from age 16 years)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Pulmonology</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Dermatology</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dermatology</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Ophthalmology</td>
<td align="left" colspan="1" rowspan="1" valign="top">Ophthalmology</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Radiology (affiliated children's hospital)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Radiology</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Neurosurgery (affiliated hospital)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Neurosurgery (affiliated hospital)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Epilepsy surgery (affiliated hospital)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Epilepsy surgery (affiliated hospital)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Dentistry</td>
<td align="left" colspan="1" rowspan="1" valign="top">Dentistry</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top"></td>
<td align="left" colspan="1" rowspan="1" valign="top">Gynecology</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Psychology</td>
<td align="left" colspan="1" rowspan="1" valign="top">Psychology</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Social worker</td>
<td align="left" colspan="1" rowspan="1" valign="top">Social worker</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">Molecular laboratory (NGS, MLPA)</td>
<td align="left" colspan="1" rowspan="1" valign="top">Molecular laboratory (NGS, MLPA)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="ajmgc31653-note-0001">
<p>Abbreviations: DAMA, disabled advanced medical assistance; MLPA, multiplex ligation‐dependent probe amplification; NGS, next generation sequencing.</p>
</fn>
</table-wrap-foot>
</table-wrap>
<fig fig-type="Figure" id="ajmgc31653-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>Schematic overview illustrating the healthcare transition process from childhood to adulthood at the pediatric and adult TSC clinic of San Paolo University Hospital in Milan, Italy. DAMA, disabled advanced medical assistance; PCP, primary care physician</p>
</caption>
<graphic id="nlm-graphic-11" xlink:href="AJMG-178-355-g001"></graphic>
</fig>
<p>Clinical care is coordinated by a pediatric neurologist and a pediatrician for children up to age 14 years, and by a neurologist for adolescents and adult patients. These physicians serve as clinical managers in addition to their clinical duties. They keep the contact with the families and/or the individual if able to self‐manage, and schedule appointments according to the individual needs and the local and international guidelines on surveillance and management (Krueger &amp; Northrup, <xref ref-type="ref" rid="ajmgc31653-bib-0033">2013</xref>; PDTA, 2015, <ext-link ext-link-type="uri" xlink:href="http://malattierare.marionegri.it/images/downloads/PDTA/PDTA_schede/sclerosi_tuberosa.pdf">http://malattierare.marionegri.it/images/downloads/PDTA/PDTA_schede/sclerosi_tuberosa.pdf</ext-link>), every 6 months or on an annual basis.</p>
<p>TSC individuals are seen as outpatients with the clinic spanning one or two different days. We usually schedule five patients per week, caring for about 250 patients overall (1/3 pediatric; 2/3 adults). Admittance as inpatients is reserved to those who need EEG monitoring for drug resistant seizures, or those who need renal surgery or preoperative assessment for epilepsy surgery, and rarely to patients with acute behavioral problems or intercurrent diseases. The pediatrician, neurologist, and/or geneticist perform the last visit, reviewing all notes by previous physicians, discussing the results, and making a follow‐up plan. Genetic test is available on site, allowing a direct dialogue between the laboratory and clinicians. In case of overload, because of the increased number of patients or limited resources, patients are advised to schedule specialty appointments in other facilities and then bring the results at the visit with the pediatrician, neurologist or geneticist. Matters related to legal competency (i.e., legal independence vs guardianship) are addressed by the pediatric neurologist before age 18 years, and those related to reproductive risk are discussed by the clinical geneticist during multiple sessions starting when both parents and providers agree that the adolescents have sufficient maturity to understand it. A social worker is available to address questions about housing, employment, welfare and disability benefits, when needed. The clinical manager is also responsible for keeping in contact with the primary care physician, therapists, and patient support organizations.</p>
<p>Physicians meet on a regular basis (generally three times a year), and discuss both recent advances in the scientific literature and selected patients of particular interest or clinical difficulty. All clinical information is stored in an ad hoc database used for scientific research.</p>
<p>To minimize the risk of loss at follow‐up, because of nonadherence, missed appointments, or refusal to manage care independently (Gray, Schaefer, Resmini‐Rawlinson, &amp; Wagoner, <xref ref-type="ref" rid="ajmgc31653-bib-0023">2017</xref>) the transition coordinator usually employs a structured plan, regularly calls the patients and reminds them to maintain the clinical appointments, with the support of an administrative person. This work is time consuming and receives no special reimbursement, but it is often necessary to guarantee adherence to care.</p>
<p>A medical unit called Disabled Advanced Medical Assistance (DAMA) has a space, phone line, and personnel dedicated to patients with ID and complex disabilities and helps the clinical manager in the care of patients with ID. DAMA is composed of a specialized team of internal medicine doctors, surgeons, and registered nurses trained to care for patients with complex disabilities. It also has a fast track for patients in the Emergency Department. The DAMA database helps provide better and faster diagnosis and care when time is an important factor for successful care.</p>
<p>Ours is currently the only adult TSC clinic in northern Italy, and a formal program for transition and transfer of care was developed as follows:<list id="ajmgc31653-list-0002" list-type="order"><list-item id="ajmgc31653-li-0004"><p>For patients referred by other pediatric TSC clinics: the referring physician contacts our clinic, and sends us a referral note with clinical summary; we then call the families to schedule an appointment. Each pediatric specialist addresses the issue of transition according to his/her own experience or local protocols, and we are not aware of a common transition plan. On average, we receive 20 new referrals for adult TSC patients per year.</p></list-item><list-item id="ajmgc31653-li-0005"><p>For patients already known to our TSC clinic: the clinical manager starts addressing transition when TSC children are in their teens. The pediatrician or the child neurologist (with the support of residents) prepares a clinical summary for the new adult doctors (Table <xref ref-type="table" rid="ajmgc31653-tbl-0001">1</xref>). All healthcare practitioners have access to both the pediatric and adult electronic medical records. The same specialists, who have developed expertise in this condition, often follow the TSC patients at all ages (i.e., nephrologist). Based on our experience and considering the limited resources, this ensures continuity of care and is appreciated by the patients.</p></list-item></list>
</p>
<p>The number of patients seen in our TSC clinic has increased from few dozens in 2001–2005 to more than 250 patients in 2018, and this model has allowed us to considerably reduce the number of days TSC individuals need to travel to the hospital in a year (from many to generally two), improving their quality of life, especially for those with significant disabilities. Funding by Regione Lombardia Healthcare System allowed us to organize this model of care.</p>
<p>Although we have not performed a study to formally evaluate the outcomes of our clinic and this approach certainly has several pitfalls, our model has developed over more than 15 years, adjusting to try and balance the patients' needs and the limited resources (both economic and availability of staff). We plan on creating a questionnaire for patients/families and healthcare providers in the near future, to assess the impact of this model, its cost efficiency, and how it could be ameliorated.</p>
</sec>
<sec id="ajmgc31653-sec-0015">
<label>5</label>
<title>PROPOSAL OF HEALTHCARE TRANSITION IN TSC</title>
<p>Knowledge about the natural history of TSC‐related manifestations is a prerequisite for an effective transition. It is accepted that adult neurologists, nephrologists, pulmonologists, and psychiatrists should be involved when transitioning healthcare from childhood to adulthood in TSC (Thiele et al., <xref ref-type="ref" rid="ajmgc31653-bib-0054">2014</xref>), but how to organize the transition process is less clear. As stated by Nabbout et al. (<xref ref-type="ref" rid="ajmgc31653-bib-0043">2017</xref>), a multidisciplinary clinic is probably the ideal mode of care for these individuals, and in our opinion it should be sought whenever possible.</p>
<p>Although a unifying and worldwide model of transition in TSC would be ideal, we conclude that it may not be applicable—and would likely not be successful—because of differences in regulations, costs, organization of healthcare systems, access to care, insurance systems, and so forth. This is supported by the fact that several models regarding different diseases have been reported in the literature, with no evidence that one is more effective than others (Crowley, Wolfe, Lock, &amp; McKee, <xref ref-type="ref" rid="ajmgc31653-bib-0018">2011</xref>).</p>
<p>We therefore think that each TSC clinic should find and endorse the best model that fits their practice and healthcare setting, be it a joint TSC clinic, a clinic that cares for patients throughout the life‐span, or other examples.</p>
<p>Transition (the dynamic process) is always desirable. However, transfer of care (the single event) may be required in some realities and have different timing then transition, whereas it may not be necessary in highly specialized and well‐established multidisciplinary TSC clinics that are used to caring for patients of any ages. Indeed, the latter (clinics that care for patients throughout the life‐span) may be the most suitable model, as suggested by Thiele et al. (<xref ref-type="ref" rid="ajmgc31653-bib-0054">2014</xref>) and seen in several TSC clinics in Europe and in the United States, where certain pediatric physicians are trained and certified to care also for adults, facilitating the provision of lifelong care. Such a model would ensure that healthcare practitioners have the best expertise possible and that care is easily accessible, in accordance with the needs pointed out by TSC families in a recent survey (Both et al., <xref ref-type="ref" rid="ajmgc31653-bib-0008">2018</xref>).</p>
<p>Regardless of the model that is chosen, some topics should always be covered and some basic rules should be followed when transitioning young TSC patients into adulthood, with the aim to ensure continuity of care and patients' adherence, and to minimize the drop out of patients at follow‐up.</p>
<p>According to the general consensus on transition (American Academy of Pediatrics et al. <xref ref-type="ref" rid="ajmgc31653-bib-0002">2011</xref>) and the consensus statement of the Child Neurology Foundation (Brown et al., <xref ref-type="ref" rid="ajmgc31653-bib-0010">2016</xref>), healthcare providers should start discussing the process early, involving the teens with sufficient cognitive abilities, and educating them about the disease and treatment. This will allow the families to learn more about transition and discuss the best individual plan. The medical team should recapitulate the possible medical issues of TSC in adulthood, explaining the availability of resources and how transition at their Institution will take place.</p>
<p>We also propose that the neurologist and/or the geneticist be the lead clinicians and coordinators of care in the transition process in TSC, and that a referral letter to the adult physicians—in case of transfer of care—should always be obtained, as a starting point of the transfer process. In addition to attending physicians, residents, fellows, and nurses are invaluable resources in the transition process, as well as patient support organizations.</p>
<p>The ultimate goal is to provide the patients with medically appropriate care, ensuring an uninterrupted healthcare for as long as possible.</p>
<p>With this in mind, we propose a list of basic tips to guide healthcare professionals in establishing a transition process for TSC in their clinic based on best practice (Figure <xref ref-type="fig" rid="ajmgc31653-fig-0002">2</xref>).</p>
<fig fig-type="Figure" id="ajmgc31653-fig-0002" orientation="portrait" position="float" xml:lang="en">
<label>Figure 2</label>
<caption>
<p>The four W's: Proposed list containing points to consider and basic tips when establishing a transition process for TSC. *the clinical summary should preferably include: cognitive status; molecular diagnosis; presence of clinical manifestations related to TSC, with date of the last examination performed for each; medicines and dosages; allergies; social status and concerns</p>
</caption>
<graphic id="nlm-graphic-13" xlink:href="AJMG-178-355-g002"></graphic>
</fig>
<p>Additional useful and practical resources can be obtain at:<list id="ajmgc31653-list-0003" list-type="order"><list-item id="ajmgc31653-li-0006"><p>
<ext-link ext-link-type="uri" xlink:href="https://www.gottransition.org/about/index.cfm">https://www.gottransition.org/about/index.cfm</ext-link>, a website curated by the Maternal and Child Health Bureau and The National Alliance to Advance Adolescent Health of the United States, aimed at providing innovative strategies of transition for health professionals, youth, and families;</p></list-item><list-item id="ajmgc31653-li-0007"><p>
<ext-link ext-link-type="uri" xlink:href="https://www.nice.org.uk/guidance/ng43">https://www.nice.org.uk/guidance/ng43</ext-link>, the website of the National Institute for Health and Care Excellence in the United Kingdom, providing national guidance and advice to improve health and social care for both professionals and the general public.</p></list-item></list>
</p>
</sec>
<sec id="ajmgc31653-sec-0016">
<label>6</label>
<title>CONCLUSIONS</title>
<p>Healthcare transition from childhood to adulthood is a process aimed at assuring continuity of care and patients adherence to medical care, promoting active involvement of the patients, whenever possible. This process in TSC may be complicated by the multisystemic nature of this condition with age‐dependent manifestations and clinical variability, and by the presence of ID in at least half of the individuals.</p>
<p>In this article, we have discussed medical issues that should be addressed during transition, and have illustrated different possible approaches to transition. We conclude that there is probably no generalizable transition model for TSC, but transition in TSC should be flexible, patient oriented, and developed in accordance with the resources available. We have also provided some key points to consider when establishing a transition program for TSC, and highlight the importance of coordinating the process and educating the adult practitioners about this condition.</p>
<p>Finally, we would like to encourage TSC experts to engage in a panel discussion that will hopefully lead to a consensus statement on guidelines for healthcare transition from childhood to adulthood in TSC.</p>
</sec>
<sec id="ajmgc31653-sec-0018" sec-type="COI-statement">
<title>CONFLICT OF INTEREST</title>
<p>None.</p>
</sec>
</body>
<back>
<ack id="ajmgc31653-sec-0017">
<title>ACKNOWLEDGMENTS</title>
<p>The authors would like to thank all the other healthcare professionals involved in the TSC clinic of the San Paolo Hospital in Milan for their valuable work and participation in the care of our patients: Francesca La Briola, Valentina Chiesa, Elena Zambrelli, Katherine Turner, Monica Saccani, Graziella Cefalo, Rosangela Arancio, Angela Volpi, Emanuele Montanari, Massimo Corona, Gianluca Imeri, Silvia Terraneo, Loredana Frattini, Chiara Bencini, Lorenzo Gualandri, Valentina Barbieri, Roberto Rozza, Luca Rossetti, Stefano Izzo, Giovanni Pompili, Federica Galli, Rosa Maria Alfano, Gaetano Bulfamante, and Gianpaolo Carrafiello. A.P. wishes to acknowledge the Foundation Blanceflor Ludovisi, née Bildt, for supporting her research abroad.</p>
</ack>
<bio id="d35e48">
<p>
<bold>A. Peron</bold> is a clinical geneticist and postdoctoral fellow at the University of Milan (Italy) and an adjunct assistant professor at the University of Utah. She serves as the geneticist of the pediatric and adult TSC clinic of San Paolo University Hospital in Milan, and her research interests focus on individuals with TSC and No Mutation Identified, and genotype–phenotype correlations. Her other research interests include dysmorphology, intellectual disability, genetics of epilepsy and autism spectrum disorder, and genomic medicine.</p>
<graphic id="nlm-graphic-1" orientation="portrait" position="anchor" xlink:href="AJMG-178-355-g003.gif">
<alt-text>biography image</alt-text>
</graphic>
</bio>
<bio id="d35e76">
<p>
<bold>M. P. Canevini</bold> is an associate professor of Child Neurology and Psychiatry at the Università degli Studi di Milano, Italy. She is the head of the Child Neuropsychiatric Unit and Epilepsy Center and the director of the TSC Clinic at San Paolo University Hospital in Milan, Italy. Her main research interests focus on epilepsy and rare diseases associated with epilepsy.</p>
<graphic id="nlm-graphic-3" orientation="portrait" position="anchor" xlink:href="AJMG-178-355-g004.gif">
<alt-text>biography image</alt-text>
</graphic>
</bio>
<bio id="d35e96">
<p>
<bold>F. Ghelma</bold> is a general surgeon and a researcher of the University of Milan (Italy). He is the chief of the Disabled Advanced Medical Assistance (DAMA) Unit of the San Paolo University Hospital in Milan. His main research interest is developing and testing new hospital organizational and care models for patients with severe intellectual disabilities. Dr. Ghelma's others research interests are treatment of functional pharingo‐oesophageal disorders and oncological surgery for people with severe intellectual disability.</p>
<graphic id="nlm-graphic-5" orientation="portrait" position="anchor" xlink:href="AJMG-178-355-g005.gif">
<alt-text>biography image</alt-text>
</graphic>
</bio>
<bio id="d35e116">
<p>
<bold>F. Di Marco</bold> is an associate professor at the University of Milan (Italy) and the head of the Respiratory Unit of the Papa Giovanni XXIII Hospital in Bergamo (Italy). He served as the pulmonologist of the adult TSC/LAM clinic of San Paolo Hospital in Milan (Italy) until July 2018. His other research interests include pathophysiology of respiratory disease, including asthma and COPD.</p>
<graphic id="nlm-graphic-7" orientation="portrait" position="anchor" xlink:href="AJMG-178-355-g006.gif">
<alt-text>biography image</alt-text>
</graphic>
</bio>
<bio id="d35e138">
<p>
<bold>A. Vignoli</bold> is a senior assistant professor in Child Neurology and Psychiatry at the Department of Health Sciences, University of Milan, Italy. She has published widely on seizures, treatment, and behavioral outcomes in children with epilepsy. Her research has focused on children with epilepsy and rare diseases, in particular with drug resistant seizures.</p>
<graphic id="nlm-graphic-9" orientation="portrait" position="anchor" xlink:href="AJMG-178-355-g007.gif">
<alt-text>biography image</alt-text>
</graphic>
</bio>
<ref-list content-type="cited-references" id="ajmgc31653-bibl-0001">
<title>REFERENCES</title>
<ref id="ajmgc31653-bib-0001">
<mixed-citation id="ajmgc31653-cit-0001" publication-type="journal">
<collab collab-type="authors">American Academy of Pediatrics, American Academy of Family Physicians, &amp; American College of Physicians‐American Society of Internal Medicine</collab>
. (<year>2002</year>). <article-title>A consensus statement on health care transitions for young adults with special health care needs</article-title>. <source xml:lang="en"/>Pediatrics, <volume>110</volume>(<issue>6</issue>), <fpage>1304</fpage>–<lpage>1306</lpage>.<pub-id pub-id-type="pmid">12456949</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0002">
<mixed-citation id="ajmgc31653-cit-0002" publication-type="journal">
<collab collab-type="authors">American Academy of Pediatrics, American Academy of Family Physicians, American College of Physicians, Transitions Authoring Group</collab>
, <string-name>
<surname>Cooley</surname>, <given-names>W. C.</given-names>
</string-name>, &amp; <string-name>
<surname>Sagerman</surname>, <given-names>P. J.</given-names>
</string-name> (<year>2011</year>). <article-title>Clinical report—Supporting the health care transition from adolescence to adulthood in the medical home</article-title>. <source xml:lang="en"/>Pediatrics, <volume>128</volume>(<issue>1</issue>), <fpage>182</fpage>–<lpage>200</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2011-0969</pub-id>
<pub-id pub-id-type="pmid">21708806</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0003">
<mixed-citation id="ajmgc31653-cit-0003" publication-type="journal">
<string-name>
<surname>Amin</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Lux</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Calder</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Laugharne</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Osborne</surname>, <given-names>J.</given-names>
</string-name>, &amp; <string-name>
<surname>O'callaghan</surname>, <given-names>F.</given-names>
</string-name> (<year>2017</year>). <article-title>Causes of mortality in individuals with tuberous sclerosis complex</article-title>. <source xml:lang="en"/>Developmental Medicine and Child Neurololgy, <volume>59</volume>(<issue>6</issue>), <fpage>612</fpage>–<lpage>617</lpage>. <pub-id pub-id-type="doi">10.1111/dmcn.13352</pub-id>
</mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0004">
<mixed-citation id="ajmgc31653-cit-0004" publication-type="journal">
<string-name>
<surname>Avila</surname>, <given-names>N. A.</given-names>
</string-name>, <string-name>
<surname>Dwyer</surname>, <given-names>A. J.</given-names>
</string-name>, <string-name>
<surname>Rabel</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Darling</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Hong</surname>, <given-names>C. H.</given-names>
</string-name>, &amp; <string-name>
<surname>Moss</surname>, <given-names>J.</given-names>
</string-name> (<year>2010</year>). <article-title>CT of sclerotic bone lesions: Imaging features differentiating tuberous sclerosis complex with lymphangioleiomyomatosis from sporadic lymphangioleiomymatosis</article-title>. <source xml:lang="en"/>Radiology, <volume>254</volume>(<issue>3</issue>), <fpage>851</fpage>–<lpage>857</lpage>. <pub-id pub-id-type="doi">10.1148/radiol.09090227</pub-id>
<pub-id pub-id-type="pmid">20177097</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0005">
<mixed-citation id="ajmgc31653-cit-0005" publication-type="journal">
<string-name>
<surname>Bissler</surname>, <given-names>J. J.</given-names>
</string-name>, <string-name>
<surname>Kingswood</surname>, <given-names>J. C.</given-names>
</string-name>, <string-name>
<surname>Radzikowska</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Zonnenberg</surname>, <given-names>B. A.</given-names>
</string-name>, <string-name>
<surname>Belousova</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Frost</surname>, <given-names>M. D.</given-names>
</string-name>, … <string-name>
<surname>Budde</surname>, <given-names>K.</given-names>
</string-name> (<year>2017</year>). <article-title>Everolimus long‐term use in patients with tuberous sclerosis complex: Four‐year update of the EXIST‐2 study</article-title>. <source xml:lang="en"/>PLoS One, <volume>12</volume>(<issue>8</issue>), <fpage>e0180939</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0180939</pub-id>
<pub-id pub-id-type="pmid">28792952</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0006">
<mixed-citation id="ajmgc31653-cit-0006" publication-type="journal">
<string-name>
<surname>Blum</surname>, <given-names>R. W.</given-names>
</string-name>, <string-name>
<surname>Garell</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Hodgman</surname>, <given-names>C. H.</given-names>
</string-name>, <string-name>
<surname>Jorissen</surname>, <given-names>T. W.</given-names>
</string-name>, <string-name>
<surname>Okinow</surname>, <given-names>N. A.</given-names>
</string-name>, <string-name>
<surname>Orr</surname>, <given-names>D. P.</given-names>
</string-name>, &amp; <string-name>
<surname>Slap</surname>, <given-names>G. B.</given-names>
</string-name> (<year>1993</year>). <article-title>Transition from child‐centered to adult health‐care systems for adolescents with chronic conditions. A position paper of the Society for Adolescent Medicine</article-title>. <source xml:lang="en"/>Journal of Adolescent Health, <volume>14</volume>(<issue>7</issue>), <fpage>570</fpage>–<lpage>576</lpage>.<pub-id pub-id-type="pmid">8312295</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0007">
<mixed-citation id="ajmgc31653-cit-0007" publication-type="journal">
<string-name>
<surname>Boronat</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Barber</surname>, <given-names>I.</given-names>
</string-name>, &amp; <string-name>
<surname>Thiele</surname>, <given-names>E. A.</given-names>
</string-name> (<year>2017</year>). <article-title>Sclerotic bone lesions in tuberous sclerosis complex: A genotype‐phenotype study</article-title>. <source xml:lang="en"/>American Journal of Medical Genetics Part A, <volume>173</volume>, <fpage>1891</fpage>–<lpage>1895</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.38260</pub-id>
<pub-id pub-id-type="pmid">28488386</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0008">
<mixed-citation id="ajmgc31653-cit-0008" publication-type="journal">
<string-name>
<surname>Both</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Ten Holt</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Mous</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Patist</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Rietman</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Dieleman</surname>, <given-names>G.</given-names>
</string-name>, … <string-name>
<surname>van Eeghen</surname>, <given-names>A.</given-names>
</string-name> (<year>2018</year>). <article-title>Tuberous sclerosis complex: Concerns and needs of patients and parents from the transitional period to adulthood</article-title>. <source xml:lang="en"/>Epilepsy and Behavior, <volume>83</volume>, <fpage>13</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2018.03.012</pub-id>
<pub-id pub-id-type="pmid">29631156</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0009">
<mixed-citation id="ajmgc31653-cit-0009" publication-type="journal">
<string-name>
<surname>Brakemeier</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Vogt</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Adams</surname>, <given-names>L. C.</given-names>
</string-name>, <string-name>
<surname>Zukunft</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Diederichs</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Hamm</surname>, <given-names>B.</given-names>
</string-name>, … <string-name>
<surname>Makowski</surname>, <given-names>M. R.</given-names>
</string-name> (<year>2018</year>). <article-title>Sclerotic bone lesions as a potential imaging biomarker for the diagnosis of tuberous sclerosis complex</article-title>. <source xml:lang="en"/>Scientific Reports, <volume>8</volume>(<issue>1</issue>), <fpage>953</fpage>
<pub-id pub-id-type="doi">10.1038/s41598-018-19399-7</pub-id>
<pub-id pub-id-type="pmid">29343816</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0010">
<mixed-citation id="ajmgc31653-cit-0010" publication-type="journal">
<string-name>
<surname>Brown</surname>, <given-names>L. W.</given-names>
</string-name>, <string-name>
<surname>Camfield</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Capers</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Cascino</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Ciccarelli</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>de Gusmao</surname>, <given-names>C. M.</given-names>
</string-name>, … <string-name>
<surname>Zupanc</surname>, <given-names>M.</given-names>
</string-name> (<year>2016</year>). <article-title>The neurologist's role in supporting transition to adult health care: A consensus statement</article-title>. <source xml:lang="en"/>Neurology, <volume>87</volume>(<issue>8</issue>), <fpage>835</fpage>–<lpage>840</lpage>. <pub-id pub-id-type="doi">10.1212/WNL.0000000000002965</pub-id>
<pub-id pub-id-type="pmid">27466477</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0011">
<mixed-citation id="ajmgc31653-cit-0011" publication-type="journal">
<string-name>
<surname>Camfield</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Camfield</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Busiah</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Cohen</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Pack</surname>, <given-names>A.</given-names>
</string-name>, &amp; <string-name>
<surname>Nabbout</surname>, <given-names>R.</given-names>
</string-name> (<year>2017</year>). <article-title>The transition from pediatric to adult care for youth with epilepsy: Basic biological, sociological, and psychological issues</article-title>. <source xml:lang="en"/>Epilepsy and Behavior, <volume>69</volume>, <fpage>170</fpage>–<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2016.11.009</pub-id>
<pub-id pub-id-type="pmid">28089368</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0012">
<mixed-citation id="ajmgc31653-cit-0012" publication-type="journal">
<string-name>
<surname>Carrizosa</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>An</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Appleton</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Camfield</surname>, <given-names>P.</given-names>
</string-name>, &amp; <string-name>
<surname>Von Moers</surname>, <given-names>A.</given-names>
</string-name> (<year>2014</year>). <article-title>Models for transition clinics</article-title>. <source xml:lang="en"/>Epilepsia, <volume>55</volume>(<issue>Suppl 3</issue>), <fpage>46</fpage>–<lpage>51</lpage>. <pub-id pub-id-type="doi">10.1111/epi.12716</pub-id>
<pub-id pub-id-type="pmid">25209087</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0013">
<mixed-citation id="ajmgc31653-cit-0013" publication-type="journal">
<string-name>
<surname>Chabrol</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Jacquin</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Francois</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Broué</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Dobbelaere</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Douillard</surname>, <given-names>C.</given-names>
</string-name>, … <string-name>
<surname>Belmatoug</surname>, <given-names>N.</given-names>
</string-name> (<year>2018</year>). <article-title>Transition from pediatric to adult care in adolescents with hereditary metabolic diseases: Specific guidelines from the French network for rare inherited metabolic diseases (G2M)</article-title>. <source xml:lang="en"/>Archives de Pédiatrie. <pub-id pub-id-type="doi">10.1016/j.arcped.2018.05.009</pub-id>
</mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0014">
<mixed-citation id="ajmgc31653-cit-0014" publication-type="journal">
<string-name>
<surname>Chaudhry</surname>, <given-names>S. R.</given-names>
</string-name>, <string-name>
<surname>Keaton</surname>, <given-names>M.</given-names>
</string-name>, &amp; <string-name>
<surname>Nasr</surname>, <given-names>S. Z.</given-names>
</string-name> (<year>2013</year>). <article-title>Evaluation of a cystic fibrosis transition program from pediatric to adult care</article-title>. <source xml:lang="en"/>Pediatric Pulmonology, <volume>48</volume>(<issue>7</issue>), <fpage>658</fpage>–<lpage>665</lpage>. <pub-id pub-id-type="doi">10.1002/ppul.22647</pub-id>
<pub-id pub-id-type="pmid">22888094</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0015">
<mixed-citation id="ajmgc31653-cit-0015" publication-type="journal">
<string-name>
<surname>Chu‐Shore</surname>, <given-names>C. J.</given-names>
</string-name>, <string-name>
<surname>Major</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Camposano</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Muzykewicz</surname>, <given-names>D.</given-names>
</string-name>, &amp; <string-name>
<surname>Thiele</surname>, <given-names>E. A.</given-names>
</string-name> (<year>2010</year>). <article-title>The natural history of epilepsy in tuberous sclerosis complex</article-title>. <source xml:lang="en"/>Epilepsia, <volume>51</volume>(<issue>7</issue>), <fpage>1236</fpage>–<lpage>1241</lpage>. <pub-id pub-id-type="doi">10.1111/j.1528-1167.2009.02474.x</pub-id>
<pub-id pub-id-type="pmid">20041940</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0016">
<mixed-citation id="ajmgc31653-cit-0016" publication-type="journal">
<string-name>
<surname>Cockerell</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Guenin</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Heimdal</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Bjørnvold</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Selmer</surname>, <given-names>K. K.</given-names>
</string-name>, &amp; <string-name>
<surname>Rouvière</surname>, <given-names>O.</given-names>
</string-name> (<year>2018</year>). <article-title>Renal manifestations of tuberous sclerosis complex: patients' and parents' knowledge and routines for renal follow‐up—A questionnaire study</article-title>. <source xml:lang="en"/>BMC Nephrology, <volume>19</volume>(<issue>1</issue>), <fpage>39</fpage>
<pub-id pub-id-type="doi">10.1186/s12882-018-0835-3</pub-id>
<pub-id pub-id-type="pmid">29439672</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0017">
<mixed-citation id="ajmgc31653-cit-0017" publication-type="journal">
<string-name>
<surname>Couce</surname>, <given-names>M. L.</given-names>
</string-name>, <string-name>
<surname>Del Toro</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>García‐Jiménez</surname>, <given-names>M. C.</given-names>
</string-name>, <string-name>
<surname>Gutierrez‐Solana</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Hermida‐Ameijeiras</surname>, <given-names>Á.</given-names>
</string-name>, <string-name>
<surname>López‐Rodríguez</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Torralba</surname>, <given-names>M. Á.</given-names>
</string-name> (<year>2018</year>). <article-title>Transition from paediatric care to adult care for patients with mucopolysaccharidosis</article-title>. <source xml:lang="en"/>Revista Clinica Española, <volume>218</volume>(<issue>1</issue>), <fpage>17</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.rce.2017.06.005</pub-id>
<pub-id pub-id-type="pmid">28732796</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0018">
<mixed-citation id="ajmgc31653-cit-0018" publication-type="journal">
<string-name>
<surname>Crowley</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Wolfe</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Lock</surname>, <given-names>K.</given-names>
</string-name>, &amp; <string-name>
<surname>McKee</surname>, <given-names>M.</given-names>
</string-name> (<year>2011</year>). <article-title>Improving the transition between paediatric and adult healthcare: A systematic review</article-title>. <source xml:lang="en"/>Archives of Disease in Childhood, <volume>96</volume>(<issue>6</issue>), <fpage>548</fpage>–<lpage>553</lpage>. <pub-id pub-id-type="doi">10.1136/adc.2010.202473</pub-id>
<pub-id pub-id-type="pmid">21388969</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0019">
<mixed-citation id="ajmgc31653-cit-0019" publication-type="journal">
<string-name>
<surname>Curatolo</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Moavero</surname>, <given-names>R.</given-names>
</string-name>, &amp; <string-name>
<surname>de Vries</surname>, <given-names>P.</given-names>
</string-name> (<year>2015</year>). <article-title>Neurological and neuropsychiatric aspects of tuberous sclerosis complex</article-title>. <source xml:lang="en"/>Lancet Neurology, <volume>14</volume>(<issue>7</issue>), <fpage>733</fpage>–<lpage>745</lpage>. <pub-id pub-id-type="doi">10.1016/S1474-4422(15)00069-1</pub-id>
<pub-id pub-id-type="pmid">26067126</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0020">
<mixed-citation id="ajmgc31653-cit-0020" publication-type="journal">
<string-name>
<surname>Di Marco</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Terraneo</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Imeri</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Palumbo</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>La Briola</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Tresoldi</surname>, <given-names>S.</given-names>
</string-name>, … <string-name>
<surname>Centanni</surname>, <given-names>S.</given-names>
</string-name> (<year>2016</year>). <article-title>Women with TSC: Relationship between clinical, lung function and radiological features in a genotyped population investigated for Lymphangioleiomyomatosis</article-title>. <source xml:lang="en"/>PLoS One, <volume>11</volume>(<issue>5</issue>), <fpage>e0155331</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0155331</pub-id>
<pub-id pub-id-type="pmid">27171001</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0021">
<mixed-citation id="ajmgc31653-cit-0021" publication-type="journal">
<string-name>
<surname>Eden</surname>, <given-names>K. E.</given-names>
</string-name>, <string-name>
<surname>de Vries</surname>, <given-names>P. J.</given-names>
</string-name>, <string-name>
<surname>Moss</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Richards</surname>, <given-names>C.</given-names>
</string-name>, &amp; <string-name>
<surname>Oliver</surname>, <given-names>C.</given-names>
</string-name> (<year>2014</year>). <article-title>Self‐injury and aggression in tuberous sclerosis complex: Cross syndrome comparison and associated risk markers</article-title>. <source xml:lang="en"/>Journal of Neurodevelopmental Disorders, <volume>6</volume>(<issue>1</issue>), <fpage>10</fpage>
<pub-id pub-id-type="doi">10.1186/1866-1955-6-10</pub-id>
<pub-id pub-id-type="pmid">24822087</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0022">
<mixed-citation id="ajmgc31653-cit-0022" publication-type="journal">
<string-name>
<surname>Gabriel</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>McManus</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Rogers</surname>, <given-names>K.</given-names>
</string-name>, &amp; <string-name>
<surname>White</surname>, <given-names>P.</given-names>
</string-name> (<year>2017</year>). <article-title>Outcome evidence for structured pediatric to adult health care transition interventions: A systematic review</article-title>. <source xml:lang="en"/>Journal of Pediatrics, <volume>188</volume>, <fpage>263</fpage>–<lpage>269.e15</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpeds.2017.05.066</pub-id>
<pub-id pub-id-type="pmid">28668449</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0023">
<mixed-citation id="ajmgc31653-cit-0023" publication-type="journal">
<string-name>
<surname>Gray</surname>, <given-names>W. N.</given-names>
</string-name>, <string-name>
<surname>Schaefer</surname>, <given-names>M. R.</given-names>
</string-name>, <string-name>
<surname>Resmini‐Rawlinson</surname>, <given-names>A.</given-names>
</string-name>, &amp; <string-name>
<surname>Wagoner</surname>, <given-names>S. T.</given-names>
</string-name> (<year>2017</year>). <article-title>Barriers to transition from pediatric to adult care: A systematic review</article-title>. <source xml:lang="en"/>Journal of Pediatric Psychology, <volume>43</volume>(<issue>5</issue>), <fpage>488</fpage>–<lpage>502</lpage>. <pub-id pub-id-type="doi">10.1093/jpepsy/jsx142</pub-id>
</mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0024">
<mixed-citation id="ajmgc31653-cit-0024" publication-type="journal">
<string-name>
<surname>Hamer</surname>, <given-names>H. M.</given-names>
</string-name>, <string-name>
<surname>Pfäfflin</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Baier</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Bösebeck</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Franz</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Holtkamp</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Brandt</surname>, <given-names>C.</given-names>
</string-name> (<year>2018</year>). <article-title>Characteristics and healthcare situation of adult patients with tuberous sclerosis complex in German epilepsy centers</article-title>. <source xml:lang="en"/>Epilepsy and Behavior, <volume>82</volume>, <fpage>64</fpage>–<lpage>67</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2018.03.006</pub-id>
<pub-id pub-id-type="pmid">29587187</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0025">
<mixed-citation id="ajmgc31653-cit-0025" publication-type="journal">
<string-name>
<surname>Hancock</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Tomkins</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Sampson</surname>, <given-names>J.</given-names>
</string-name>, &amp; <string-name>
<surname>Osborne</surname>, <given-names>J.</given-names>
</string-name> (<year>2002</year>). <article-title>Lymphangioleiomyomatosis and tuberous sclerosis</article-title>. <source xml:lang="en"/>Respiratory Medicine, <volume>96</volume>(<issue>1</issue>), <fpage>7</fpage>–<lpage>13</lpage>.<pub-id pub-id-type="pmid">11863212</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0027">
<mixed-citation id="ajmgc31653-cit-0027" publication-type="journal">
<string-name>
<surname>Johnson</surname>, <given-names>S. R.</given-names>
</string-name>, <string-name>
<surname>Cordier</surname>, <given-names>J. F.</given-names>
</string-name>, <string-name>
<surname>Lazor</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Cottin</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Costabel</surname>, <given-names>U.</given-names>
</string-name>, <string-name>
<surname>Harari</surname>, <given-names>S.</given-names>
</string-name>, … <string-name>
<surname>Kingswood</surname>, <given-names>C.</given-names>
</string-name> (<year>2010</year>). <article-title>European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis</article-title>. <source xml:lang="en"/>European Respiratory Journal, <volume>35</volume>(<issue>1</issue>), <fpage>14</fpage>–<lpage>26</lpage>. <pub-id pub-id-type="doi">10.1183/09031936.00076209</pub-id>
<pub-id pub-id-type="pmid">20044458</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0028">
<mixed-citation id="ajmgc31653-cit-0028" publication-type="journal">
<string-name>
<surname>Kerr</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Kluger</surname>, <given-names>G.</given-names>
</string-name>, &amp; <string-name>
<surname>Philip</surname>, <given-names>S.</given-names>
</string-name> (<year>2011</year>). <article-title>Evolution and management of Lennox‐Gastaut syndrome through adolescence and into adulthood: Are seizures always the primary issue?</article-title>
<source xml:lang="en"/>Epileptic Disorders, <volume>13</volume>(<issue>Suppl 1</issue>), <fpage>S15</fpage>–<lpage>S26</lpage>. <pub-id pub-id-type="doi">10.1684/epd.2011.0409</pub-id>
<pub-id pub-id-type="pmid">21669559</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0029">
<mixed-citation id="ajmgc31653-cit-0029" publication-type="journal">
<string-name>
<surname>Kilincaslan</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Kok</surname>, <given-names>B. E.</given-names>
</string-name>, <string-name>
<surname>Tekturk</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Yalcinkaya</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Ozkara</surname>, <given-names>C.</given-names>
</string-name>, &amp; <string-name>
<surname>Yapici</surname>, <given-names>Z.</given-names>
</string-name> (<year>2017</year>). <article-title>Beneficial effects of Everolimus on autism and attention‐deficit/hyperactivity disorder symptoms in a Group of Patients with tuberous sclerosis complex</article-title>. <source xml:lang="en"/>Journal of Child and Adolescent Psychopharmacology, <volume>27</volume>(<issue>4</issue>), <fpage>383</fpage>–<lpage>388</lpage>. <pub-id pub-id-type="doi">10.1089/cap.2016.0100</pub-id>
<pub-id pub-id-type="pmid">27797585</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0030">
<mixed-citation id="ajmgc31653-cit-0030" publication-type="journal">
<string-name>
<surname>Kingswood</surname>, <given-names>J. C.</given-names>
</string-name>, <string-name>
<surname>Bissler</surname>, <given-names>J. J.</given-names>
</string-name>, <string-name>
<surname>Budde</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Hulbert</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Guay‐Woodford</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Sampson</surname>, <given-names>J. R.</given-names>
</string-name>, … <string-name>
<surname>Zonnenberg</surname>, <given-names>B. A.</given-names>
</string-name> (<year>2016</year>). <article-title>Review of the tuberous sclerosis renal guidelines from the 2012 consensus conference: Current data and future study</article-title>. <source xml:lang="en"/>Nephron, <volume>134</volume>(<issue>2</issue>), <fpage>51</fpage>–<lpage>58</lpage>. <pub-id pub-id-type="doi">10.1159/000448293</pub-id>
<pub-id pub-id-type="pmid">27504842</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0031">
<mixed-citation id="ajmgc31653-cit-0031" publication-type="journal">
<string-name>
<surname>Koenig</surname>, <given-names>M.K.</given-names>
</string-name>, <string-name>
<surname>Bell</surname>, <given-names>C.S.</given-names>
</string-name>, <string-name>
<surname>Hebert</surname>, <given-names>A.A.</given-names>
</string-name>, <string-name>
<surname>Roberson</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Samuels</surname>, <given-names>J.A.</given-names>
</string-name>, <string-name>
<surname>Slopis</surname>, <given-names>J.M</given-names>
</string-name>. … <collab collab-type="authors">TREATMENT Trial Collaborators</collab>
. (<year>2018</year>) <article-title>Efficacy and safety of topical rapamycin in patients with facial Angiofibromas secondary to tuberous sclerosis complex: The TREATMENT randomized clinical trial</article-title>
<source xml:lang="en"/>JAMA Dermatology, <volume>154</volume>(<issue>7</issue>), <fpage>773</fpage>–<lpage>780</lpage>. <pub-id pub-id-type="doi">10.1001/jamadermatol.2018.0464</pub-id>.<pub-id pub-id-type="pmid">29800048</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0032">
<mixed-citation id="ajmgc31653-cit-0032" publication-type="journal">
<string-name>
<surname>Kothare</surname>, <given-names>S. V.</given-names>
</string-name>, <string-name>
<surname>Singh</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Chalifoux</surname>, <given-names>J. R.</given-names>
</string-name>, <string-name>
<surname>Staley</surname>, <given-names>B. A.</given-names>
</string-name>, <string-name>
<surname>Weiner</surname>, <given-names>H. L.</given-names>
</string-name>, <string-name>
<surname>Menzer</surname>, <given-names>K.</given-names>
</string-name>, &amp; <string-name>
<surname>Devinsky</surname>, <given-names>O.</given-names>
</string-name> (<year>2014</year>). <article-title>Severity of manifestations in tuberous sclerosis complex in relation to genotype</article-title>. <source xml:lang="en"/>Epilepsia, <volume>55</volume>(<issue>7</issue>), <fpage>1025</fpage>–<lpage>1029</lpage>. <pub-id pub-id-type="doi">10.1111/epi.12680</pub-id>
<pub-id pub-id-type="pmid">24917535</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0033">
<mixed-citation id="ajmgc31653-cit-0033" publication-type="journal">
<string-name>
<surname>Krueger</surname>, <given-names>D. A.</given-names>
</string-name>, <string-name>
<surname>Northrup</surname>, <given-names>H.</given-names>
</string-name>, &amp; <collab collab-type="authors">International Tuberous Sclerosis Complex Consensus Group</collab>
. (<year>2013</year>). <article-title>Tuberous sclerosis complex surveillance and management: Recommendations of the 2012 international tuberous sclerosis complex consensus conference</article-title>. <source xml:lang="en"/>Pediatric Neurology, <volume>49</volume>(<issue>4</issue>), <fpage>255</fpage>–<lpage>265</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2013.08.002</pub-id>
<pub-id pub-id-type="pmid">24053983</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0034">
<mixed-citation id="ajmgc31653-cit-0034" publication-type="journal">
<string-name>
<surname>Krueger</surname>, <given-names>D. A.</given-names>
</string-name>, <string-name>
<surname>Sadhwani</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Byars</surname>, <given-names>A. W.</given-names>
</string-name>, <string-name>
<surname>de Vries</surname>, <given-names>P. J.</given-names>
</string-name>, <string-name>
<surname>Franz</surname>, <given-names>D. N.</given-names>
</string-name>, <string-name>
<surname>Whittemore</surname>, <given-names>V. H.</given-names>
</string-name>, … <string-name>
<surname>Sahin</surname>, <given-names>M.</given-names>
</string-name> (<year>2017</year>). <article-title>Everolimus for treatment of tuberous sclerosis complex‐associated neuropsychiatric disorders</article-title>. <source xml:lang="en"/>Annals of Clinical and Translational Neurology, <volume>4</volume>(<issue>12</issue>), <fpage>877</fpage>–<lpage>887</lpage>. <pub-id pub-id-type="doi">10.1002/acn3.494</pub-id>
<pub-id pub-id-type="pmid">29296616</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0035">
<mixed-citation id="ajmgc31653-cit-0035" publication-type="journal">
<string-name>
<surname>Joinson</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>O'Callaghan</surname>, <given-names>F. J.</given-names>
</string-name>, <string-name>
<surname>Osborne</surname>, <given-names>J. P.</given-names>
</string-name>, <string-name>
<surname>Martyn</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Harris</surname>, <given-names>T.</given-names>
</string-name>, &amp; <string-name>
<surname>Bolton</surname>, <given-names>P. F.</given-names>
</string-name> (<year>2003</year>). <article-title>Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex</article-title>. <source xml:lang="en"/>Psychological Medicine, <volume>33</volume>(<issue>2</issue>), <fpage>335</fpage>–<lpage>344</lpage>.<pub-id pub-id-type="pmid">12622312</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0036">
<mixed-citation id="ajmgc31653-cit-0036" publication-type="journal">
<string-name>
<surname>Jurasek</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Ray</surname>, <given-names>L.</given-names>
</string-name>, &amp; <string-name>
<surname>Quigley</surname>, <given-names>D.</given-names>
</string-name> (<year>2010</year>). <article-title>Development and implementation of an adolescent epilepsy transition clinic</article-title>. <source xml:lang="en"/>Journal of Neuroscience Nursing, <volume>42</volume>(<issue>4</issue>), <fpage>181</fpage>–<lpage>189</lpage>.<pub-id pub-id-type="pmid">20804112</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0037">
<mixed-citation id="ajmgc31653-cit-0037" publication-type="journal">
<string-name>
<surname>Lai</surname>, <given-names>M. C.</given-names>
</string-name>, <string-name>
<surname>Lombardo</surname>, <given-names>M. V.</given-names>
</string-name>, &amp; <string-name>
<surname>Baron‐Cohen</surname>, <given-names>S.</given-names>
</string-name> (<year>2014</year>). <article-title>Autism</article-title>. <source xml:lang="en"/>Lancet, <volume>383</volume>(<issue>9920</issue>), <fpage>896</fpage>–<lpage>910</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(13)61539-1</pub-id>
<pub-id pub-id-type="pmid">24074734</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0038">
<mixed-citation id="ajmgc31653-cit-0038" publication-type="journal">
<string-name>
<surname>Leclezio</surname>, <given-names>L.</given-names>
</string-name>, &amp; <string-name>
<surname>de Vries</surname>, <given-names>P. J.</given-names>
</string-name> (<year>2015</year>). <article-title>Advances in the treatment of tuberous sclerosis complex</article-title>. <source xml:lang="en"/>Current Opinion in Psychiatry, <volume>28</volume>(<issue>2</issue>), <fpage>113</fpage>–<lpage>120</lpage>. <pub-id pub-id-type="doi">10.1097/YCO.0000000000000136</pub-id>.<pub-id pub-id-type="pmid">25602245</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0039">
<mixed-citation id="ajmgc31653-cit-0039" publication-type="journal">
<string-name>
<surname>Malissen</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Vergely</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Simon</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Roubertie</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Malinge</surname>, <given-names>M. C.</given-names>
</string-name>, &amp; <string-name>
<surname>Bessis</surname>, <given-names>D.</given-names>
</string-name> (<year>2017</year>). <article-title>Long‐term treatment of cutaneous manifestations of tuberous sclerosis complex with topical 1% sirolimus cream: A prospective study of 25 patients</article-title>. <source xml:lang="en"/>Journal of the American Academy of Dermatology, <volume>77</volume>(<issue>3</issue>), <fpage>464</fpage>–<lpage>472.e3</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaad.2017.04.005</pub-id>
<pub-id pub-id-type="pmid">28502378</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0040">
<mixed-citation id="ajmgc31653-cit-0040" publication-type="journal">
<string-name>
<surname>Mütze</surname>, <given-names>U.</given-names>
</string-name>, <string-name>
<surname>Roth</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Weigel</surname>, <given-names>J. F.</given-names>
</string-name>, <string-name>
<surname>Beblo</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Baerwald</surname>, <given-names>C. G.</given-names>
</string-name>, <string-name>
<surname>Bührdel</surname>, <given-names>P.</given-names>
</string-name>, &amp; <string-name>
<surname>Kiess</surname>, <given-names>W.</given-names>
</string-name> (<year>2011</year>). <article-title>Transition of young adults with phenylketonuria from pediatric to adult care</article-title>. <source xml:lang="en"/>Journal of Inherited Metabolic Disease, <volume>34</volume>(<issue>3</issue>), <fpage>701</fpage>–<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1007/s10545-011-9284-x</pub-id>
<pub-id pub-id-type="pmid">21305352</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0041">
<mixed-citation id="ajmgc31653-cit-0041" publication-type="journal">
<string-name>
<surname>Mütze</surname>, <given-names>U.</given-names>
</string-name>, <string-name>
<surname>Thiele</surname>, <given-names>A. G.</given-names>
</string-name>, <string-name>
<surname>Baerwald</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Ceglarek</surname>, <given-names>U.</given-names>
</string-name>, <string-name>
<surname>Kiess</surname>, <given-names>W.</given-names>
</string-name>, &amp; <string-name>
<surname>Beblo</surname>, <given-names>S.</given-names>
</string-name> (<year>2016</year>). <article-title>Ten years of specialized adult care for phenylketonuria ‐ a single‐Centre experience</article-title>. <source xml:lang="en"/>Orphanet Journal of Rare Diseases, <volume>11</volume>, <fpage>27</fpage>
<pub-id pub-id-type="doi">10.1186/s13023-016-0410-6</pub-id>
<pub-id pub-id-type="pmid">27008844</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0043">
<mixed-citation id="ajmgc31653-cit-0043" publication-type="journal">
<string-name>
<surname>Nabbout</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Andrade</surname>, <given-names>D. M.</given-names>
</string-name>, <string-name>
<surname>Bahi‐Buisson</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Cross</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Desquerre</surname>, <given-names>I.</given-names>
</string-name>, <string-name>
<surname>Dulac</surname>, <given-names>O.</given-names>
</string-name>, … <string-name>
<surname>Camfield</surname>, <given-names>C. S.</given-names>
</string-name> (<year>2017</year>). <article-title>Outcome of childhood‐onset epilepsy from adolescence to adulthood: Transition issues</article-title>. <source xml:lang="en"/>Epilepsy and Behavior, <volume>69</volume>, <fpage>161</fpage>–<lpage>169</lpage>. <pub-id pub-id-type="doi">10.1016/j.yebeh.2016.11.010</pub-id>
<pub-id pub-id-type="pmid">28256379</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0044">
<mixed-citation id="ajmgc31653-cit-0044" publication-type="journal">
<string-name>
<surname>Nellist</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Brouwer</surname>, <given-names>R. W.</given-names>
</string-name>, <string-name>
<surname>Kockx</surname>, <given-names>C. E.</given-names>
</string-name>, <string-name>
<surname>van Veghel‐Plandsoen</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Withagen‐Hermans</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Prins‐Bakker</surname>, <given-names>L.</given-names>
</string-name>, &amp; <string-name>
<surname>van IJcken</surname>, <given-names>W. F.</given-names>
</string-name> (<year>2015</year>). <article-title>Targeted next generation sequencing reveals previously unidentified TSC1 and TSC2 mutations</article-title>. <source xml:lang="en"/>BMC Medical Genetics, <volume>16</volume>, <fpage>10</fpage>
<pub-id pub-id-type="doi">10.1186/s12881-015-0155-4</pub-id>
<pub-id pub-id-type="pmid">25927202</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0045">
<mixed-citation id="ajmgc31653-cit-0045" publication-type="book">
<string-name>
<surname>Northrup</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Koenig</surname>, <given-names>M. K.</given-names>
</string-name>, <string-name>
<surname>Pearson</surname>, <given-names>D. A.</given-names>
</string-name>, &amp; <string-name>
<surname>Au</surname>, <given-names>K. S.</given-names>
</string-name> (<year>1999</year>). <chapter-title>Tuberous sclerosis complex</chapter-title> [updated July 18, 2018]. In <person-group person-group-type="editor"><name><surname>Adam</surname><given-names>M. P.</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Ardinger</surname><given-names>H. H.</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Pagon</surname><given-names>R. A.</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Wallace</surname><given-names>S. E.</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Bean</surname><given-names>L. J. H.</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Stephens</surname><given-names>K.</given-names></name></person-group>, &amp; <person-group person-group-type="editor"><name><surname>Amemiya</surname><given-names>A.</given-names></name></person-group> (Eds.), <source xml:lang="en"/>GeneReviews® [Internet]. <publisher-loc>Seattle, WA</publisher-loc>: <publisher-name>University of Washington, Seattle</publisher-name>.</mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0046">
<mixed-citation id="ajmgc31653-cit-0046" publication-type="journal">
<string-name>
<surname>Northrup</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Krueger</surname>, <given-names>D. A.</given-names>
</string-name>, &amp; <collab collab-type="authors">International Tuberous Sclerosis Complex Consensus Group</collab>
. (<year>2013</year>). <article-title>Tuberous sclerosis complex diagnostic criteria update: Recommendations of the 2012 international tuberous sclerosis complex consensus conference</article-title>. <source xml:lang="en"/>Pediatric Neurology, <volume>49</volume>(<issue>4</issue>), <fpage>243</fpage>–<lpage>254</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2013.08.001</pub-id>
<pub-id pub-id-type="pmid">24053982</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0063">
<mixed-citation id="ajmgc31653-cit-0063" publication-type="miscellaneous">PDTA (<year>2015</year>). <ext-link ext-link-type="uri" xlink:href="http://malattierare.marionegri.it/images/downloads/PDTA/PDTA_schede/sclerosi_tuberosa.pdf">http://malattierare.marionegri.it/images/downloads/PDTA/PDTA_schede/sclerosi_tuberosa.pdf</ext-link>
</mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0048">
<mixed-citation id="ajmgc31653-cit-0048" publication-type="journal">
<string-name>
<surname>Peron</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Vignoli</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>La Briola</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Volpi</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Montanari</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Morenghi</surname>, <given-names>E.</given-names>
</string-name>, … <string-name>
<surname>Canevini</surname>, <given-names>M. P.</given-names>
</string-name> (<year>2016</year>). <article-title>Do patients with tuberous sclerosis complex have an increased risk for malignancies?</article-title>
<source xml:lang="en"/>American Journal of Medical Genetics Part A, <volume>170</volume>(<issue>6</issue>), <fpage>1538</fpage>–<lpage>1544</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.37644</pub-id>
<pub-id pub-id-type="pmid">27061015</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0049">
<mixed-citation id="ajmgc31653-cit-0049" publication-type="journal">
<string-name>
<surname>Peron</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Vignoli</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>La Briola</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Morenghi</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Tansini</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Alfano</surname>, <given-names>R. M.</given-names>
</string-name>, … <collab collab-type="authors">TSC Study Group of the San Paolo Hospital of Milan</collab>
. (<year>2018</year>). <article-title>Deep phenotyping of patients with tuberous sclerosis complex and no mutation identified in TSC1 and TSC2</article-title>. <source xml:lang="en"/>European Journal of Medical Genetics, <volume>61</volume>(<issue>7</issue>), <fpage>403</fpage>–<lpage>410</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2018.02.005</pub-id>
<pub-id pub-id-type="pmid">29432982</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0050">
<mixed-citation id="ajmgc31653-cit-0050" publication-type="journal">
<string-name>
<surname>Reiss</surname>, <given-names>J. G.</given-names>
</string-name>, <string-name>
<surname>Gibson</surname>, <given-names>R. W.</given-names>
</string-name>, &amp; <string-name>
<surname>Walker</surname>, <given-names>L. R.</given-names>
</string-name> (<year>2005</year>). <article-title>Health care transition: Youth, family, and provider perspectives</article-title>. <source xml:lang="en"/>Pediatrics, <volume>115</volume>(<issue>1</issue>), <fpage>112</fpage>–<lpage>120</lpage>.<pub-id pub-id-type="pmid">15629990</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0051">
<mixed-citation id="ajmgc31653-cit-0051" publication-type="book">
<collab collab-type="authors">Royal College of Paediatrics and Child Health</collab>
. (<year>2003</year>). <source xml:lang="en"/>Bridging the gap: Health care for adolescents. <publisher-loc>London</publisher-loc>: <publisher-name>RCPCH</publisher-name>.</mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0052">
<mixed-citation id="ajmgc31653-cit-0052" publication-type="journal">
<string-name>
<surname>Shepherd</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Gomez</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Lie</surname>, <given-names>J.</given-names>
</string-name>, &amp; <string-name>
<surname>Crowson</surname>, <given-names>C.</given-names>
</string-name> (<year>1991</year>). <article-title>Causes of death in patients with tuberous sclerosis</article-title>. <source xml:lang="en"/>Mayo Clinic Proceedings, <volume>66</volume>(<issue>8</issue>), <fpage>792</fpage>–<lpage>796</lpage>.<pub-id pub-id-type="pmid">1861550</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0053">
<mixed-citation id="ajmgc31653-cit-0053" publication-type="journal">
<string-name>
<surname>Teng</surname>, <given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Cowen</surname>, <given-names>E. W.</given-names>
</string-name>, <string-name>
<surname>Wataya‐Kaneda</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Gosnell</surname>, <given-names>E. S.</given-names>
</string-name>, <string-name>
<surname>Witman</surname>, <given-names>P. M.</given-names>
</string-name>, <string-name>
<surname>Hebert</surname>, <given-names>A. A.</given-names>
</string-name>, … <string-name>
<surname>Darling</surname>, <given-names>T. N.</given-names>
</string-name> (<year>2014</year>). <article-title>Dermatologic and dental aspects of the 2012 international tuberous sclerosis complex consensus statements</article-title>. <source xml:lang="en"/>JAMA Dermatology, <volume>150</volume>(<issue>10</issue>), <fpage>1095</fpage>–<lpage>1101</lpage>. <pub-id pub-id-type="doi">10.1001/jamadermatol.2014.938</pub-id>
<pub-id pub-id-type="pmid">25029267</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0054">
<mixed-citation id="ajmgc31653-cit-0054" publication-type="journal">
<string-name>
<surname>Thiele</surname>, <given-names>E. A.</given-names>
</string-name>, <string-name>
<surname>Granata</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Matricardi</surname>, <given-names>S.</given-names>
</string-name>, &amp; <string-name>
<surname>Chugani</surname>, <given-names>H. T.</given-names>
</string-name> (<year>2014</year>). <article-title>Transition into adulthood: Tuberous sclerosis complex, Sturge‐Weber syndrome, and Rasmussen encephalitis</article-title>. <source xml:lang="en"/>Epilepsia, <volume>55</volume>(<issue>Suppl 3</issue>), <fpage>29</fpage>–<lpage>33</lpage>. <pub-id pub-id-type="doi">10.1111/epi.12722</pub-id>
</mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0055">
<mixed-citation id="ajmgc31653-cit-0055" publication-type="journal">
<string-name>
<surname>Tierney</surname>, <given-names>K. M.</given-names>
</string-name>, <string-name>
<surname>McCartney</surname>, <given-names>D. L.</given-names>
</string-name>, <string-name>
<surname>Serfontein</surname>, <given-names>J. R.</given-names>
</string-name>, &amp; <string-name>
<surname>de Vries</surname>, <given-names>P. J.</given-names>
</string-name> (<year>2011</year>). <article-title>Neuropsychological attention skills and related behaviours in adults with tuberous sclerosis complex</article-title>. <source xml:lang="en"/>Behavior Genetics, <volume>41</volume>(<issue>3</issue>), <fpage>437</fpage>–<lpage>444</lpage>. <pub-id pub-id-type="doi">10.1007/s10519-010-9423-4</pub-id>
<pub-id pub-id-type="pmid">21191642</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0056">
<mixed-citation id="ajmgc31653-cit-0056" publication-type="journal">
<string-name>
<surname>Tyburczy</surname>, <given-names>M. E.</given-names>
</string-name>, <string-name>
<surname>Dies</surname>, <given-names>K. A.</given-names>
</string-name>, <string-name>
<surname>Glass</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Camposano</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Chekaluk</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Thorner</surname>, <given-names>A. R.</given-names>
</string-name>, … <string-name>
<surname>Kwiatkowski</surname>, <given-names>D. J.</given-names>
</string-name> (<year>2015</year>). <article-title>Mosaic and Intronic mutations in TSC1/TSC2 explain the majority of TSC patients with no mutation identified by conventional testing</article-title>. <source xml:lang="en"/>PLoS Genetics, <volume>11</volume>(<issue>11</issue>), <fpage>e1005637</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1005637</pub-id>
<pub-id pub-id-type="pmid">26540169</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0057">
<mixed-citation id="ajmgc31653-cit-0057" publication-type="journal">
<string-name>
<surname>Van Lierde</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Menni</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Bedeschi</surname>, <given-names>M. F.</given-names>
</string-name>, <string-name>
<surname>Natacci</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Guez</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Vizziello</surname>, <given-names>P.</given-names>
</string-name>, … <string-name>
<surname>Esposito</surname>, <given-names>S.</given-names>
</string-name> (<year>2013</year>). <article-title>Healthcare transition in patients with rare genetic disorders with and without developmental disability: Neurofibromatosis 1 and Williams‐Beuren syndrome</article-title>. <source xml:lang="en"/>American Journal of Medical Genetics Part A, <volume>161A</volume>(<issue>7</issue>), <fpage>1666</fpage>–<lpage>1674</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.35982</pub-id>
<pub-id pub-id-type="pmid">23696535</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0058">
<mixed-citation id="ajmgc31653-cit-0058" publication-type="journal">
<string-name>
<surname>Vignoli</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>La Briola</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Turner</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Scornavacca</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Chiesa</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Zambrelli</surname>, <given-names>E.</given-names>
</string-name>, … <string-name>
<surname>Canevini</surname>, <given-names>M. P.</given-names>
</string-name> (<year>2013</year>). <article-title>Epilepsy in TSC: Certain etiology does not mean certain prognosis</article-title>. <source xml:lang="en"/>Epilepsia, <volume>54</volume>(<issue>12</issue>), <fpage>2134</fpage>–<lpage>2142</lpage>. <pub-id pub-id-type="doi">10.1111/epi.12430</pub-id>
<pub-id pub-id-type="pmid">24304436</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0059">
<mixed-citation id="ajmgc31653-cit-0059" publication-type="journal">
<string-name>
<surname>Vignoli</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>La Briola</surname>, <given-names>F.</given-names>
</string-name>, <string-name>
<surname>Peron</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Turner</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Vannicola</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Saccani</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Canevini</surname>, <given-names>M. P.</given-names>
</string-name> (<year>2015</year>). <article-title>Autism spectrum disorder in tuberous sclerosis complex: Searching for risk markers</article-title>. <source xml:lang="en"/>Orphanet Journal of Rare Diseases, <volume>10</volume>, <fpage>154</fpage>
<pub-id pub-id-type="doi">10.1186/s13023-015-0371-1</pub-id>
<pub-id pub-id-type="pmid">26631248</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0060">
<mixed-citation id="ajmgc31653-cit-0060" publication-type="journal">
<string-name>
<surname>Waldboth</surname>, <given-names>V.</given-names>
</string-name>, <string-name>
<surname>Patch</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Mahrer‐Imhof</surname>, <given-names>R.</given-names>
</string-name>, &amp; <string-name>
<surname>Metcalfe</surname>, <given-names>A.</given-names>
</string-name> (<year>2016</year>). <article-title>Living a normal life in an extraordinary way: A systematic review investigating experiences of families of young people's transition into adulthood when affected by a genetic and chronic childhood condition</article-title>. <source xml:lang="en"/>International Journal of Nursing Studies, <volume>62</volume>, <fpage>44</fpage>–<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijnurstu.2016.07.007</pub-id>
<pub-id pub-id-type="pmid">27450665</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0061">
<mixed-citation id="ajmgc31653-cit-0061" publication-type="journal">
<string-name>
<surname>Wataya‐Kaneda</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Nakamura</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Tanaka</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Hayashi</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Matsumoto</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Yamamoto</surname>, <given-names>K.</given-names>
</string-name>, &amp; <string-name>
<surname>Katayama</surname>, <given-names>I.</given-names>
</string-name> (<year>2017</year>). <article-title>Efficacy and safety of topical Sirolimus therapy for facial Angiofibromas in the tuberous sclerosis complex: A randomized clinical trial</article-title>. <source xml:lang="en"/>JAMA Dermatology, <volume>153</volume>(<issue>1</issue>), <fpage>39</fpage>–<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1001/jamadermatol.2016.3545</pub-id>
<pub-id pub-id-type="pmid">27837201</pub-id></mixed-citation>
</ref>
<ref id="ajmgc31653-bib-0062">
<mixed-citation id="ajmgc31653-cit-0062" publication-type="journal">
<string-name>
<surname>Wilde</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Eden</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>de Vries</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Moss</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Welham</surname>, <given-names>A.</given-names>
</string-name>, &amp; <string-name>
<surname>Oliver</surname>, <given-names>C.</given-names>
</string-name> (<year>2017</year>). <article-title>Self‐injury and aggression in adults with tuberous sclerosis complex: Frequency, associated person characteristics, and implications for assessment</article-title>. <source xml:lang="en"/>Research in Developmental Disabilities, <volume>64</volume>, <fpage>119</fpage>–<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1016/j.ridd.2017.03.007</pub-id>
<pub-id pub-id-type="pmid">28411579</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>